Loading company…
San Diego biotech developing immunotherapy and AAV gene therapy for cancer and cardiovascular disease.
Founded in 2011 and headquartered in San Diego, California, Theragene Pharmaceuticals, Inc. develops immunotherapy and gene therapy for cancer and cardiovascular diseases. Its gene therapy platform uses Adeno-Associated Virus (AAV) technology, and its customers include hospitals, oncology clinics and cardiovascular centers in the United States and Asia. Revenue comes from partnerships, licensing and collaborative development deals. Its most recent round was a Seed round in December 2017 that raised USD 0.20 mn from Thynk Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in